GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Abattis Bioceuticals Corp (OTCPK:ATTBF) » Definitions » Other Income (Expense)

Abattis Bioceuticals (Abattis Bioceuticals) Other Income (Expense) : $0.74 Mil (TTM As of Sep. 2019)


View and export this data going back to . Start your Free Trial

What is Abattis Bioceuticals Other Income (Expense)?

Abattis Bioceuticals's other income expense for the Abattis Bioceuticals's pretax income for the three months ended in Sep. 2019 was $-0.28 Mil. Its other income expense for the trailing twelve months (TTM) ended in Sep. 2019 was $0.74 Mil.


Abattis Bioceuticals Other Income (Expense) Historical Data

The historical data trend for Abattis Bioceuticals's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abattis Bioceuticals Other Income (Expense) Chart

Abattis Bioceuticals Annual Data
Trend Sep10 Sep11 Sep12 Sep13 Sep14 Sep15 Sep16 Sep17 Sep18 Sep19
Other Income (Expense)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.17 -0.06 -1.27 -44.10 0.76

Abattis Bioceuticals Quarterly Data
Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19
Other Income (Expense) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -44.32 0.29 0.69 0.05 -0.28

Abattis Bioceuticals Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Sep. 2019 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.74 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Abattis Bioceuticals  (OTCPK:ATTBF) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.


Abattis Bioceuticals (Abattis Bioceuticals) Business Description

Traded in Other Exchanges
N/A
Address
1200 - 625 Howe Street, Vancouver, BC, CAN, V6C 2M6
Abattis Bioceuticals Corp is a Canadian life science and biotechnology company focuses on aggregating, integrating and investing in agricultural technologies and biotechnology services for the legal cannabis industry. It is primarily engaged in producing, licensing and marketing proprietary ingredients and formulas for use in the biopharma, nutraceutical, cosmetic and animal nutrition markets. The company is also engaged in growing, extraction, testing, propagation and online distribution.

Abattis Bioceuticals (Abattis Bioceuticals) Headlines

From GuruFocus

Abattis Announces Share Buy Back Program

By Marketwired Marketwired 08-07-2018

Abattis Removed From BCSC Temporary Order

By Marketwired Marketwired 01-17-2019

Abattis Provides Marketing and Operational Updates

By Marketwired Marketwired 12-21-2018

Abattis Bioceuticals Acquires Proprietary Genetic Strain Bank

By Marketwired Marketwired 11-23-2018

Abattis Provides Update on Conference Call

By Marketwired Marketwired 02-28-2019

Abattis Bioceuticals Celebrates Legalization

By Marketwired Marketwired 10-18-2018